Literature DB >> 22923173

Cross-linking of structural proteins in ageing skin: an in situ assay for the detection of amine oxidase activity.

Abigail K Langton1, Christopher E M Griffiths, Michael J Sherratt, Rachel E B Watson.   

Abstract

With increasing age, dynamic tissues such as lungs, blood vessels and skin lose their ability to both deform and recoil, culminating in tissue stiffening. This loss of tissue elasticity, which profoundly impacts tissue function and thus morbidity, may be due not only to changes in the relative abundance of key extracellular matrix proteins within tissues but also to their accumulation of post-translational modifications. Whilst to date attention has focussed primarily on the age-related non-enzymatic formation of advanced glycation end products, the accumulation of pathological enzyme-mediated cross-links may also lead to age-related tissue stiffening. The lysyl oxidase (LOX) family of enzymes are constitutively expressed in adult tissues and are known to drive the catalysis of cross-links in both fibrillar collagens and elastin. Although immunochemical approaches are commonly used to localise the inactive pro-enzyme of LOX, and biochemical methods are employed to quantify activity in homogenised tissue, they do not allow for the in situ localisation of the enzyme. Thus, we have developed a novel assay to both detect and localise LOX enzyme activity in situ. LOX family members are amine oxidases and this assay uses the principle that an amine substrate in the presence of this class of enzyme will be oxidised to an aldehyde and hydrogen peroxide (H2O2). In turn, H2O2, when combined with luminol and horseradish peroxidase, will produce a light-emitting reaction that can be detected by film autoradiography. The development of a technique to localise specific amine oxidase activity in tissue sections may provide crucial additional information on the exact role played by this class of enzymes in mediating age-related tissue stiffening.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923173     DOI: 10.1007/s10522-012-9394-3

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  5 in total

1.  Examining the Relationships Between Bone Tissue Composition, Compositional Heterogeneity, and Fragility Fracture: A Matched Case-Controlled FTIRI Study.

Authors:  Adele L Boskey; Eve Donnelly; Elizabeth Boskey; Lyudmila Spevak; Yan Ma; Wei Zhang; Joan Lappe; Robert R Recker
Journal:  J Bone Miner Res       Date:  2015-12-24       Impact factor: 6.741

2.  Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial.

Authors:  S Bunnapradist; K Ciechanowski; P West-Thielke; S Mulgaonkar; L Rostaing; B Vasudev; K Budde
Journal:  Am J Transplant       Date:  2012-12-21       Impact factor: 8.086

3.  Combining nano-physical and computational investigations to understand the nature of "aging" in dermal collagen.

Authors:  Tarek Ahmed; Anthony Nash; Kristina En Clark; Marion Ghibaudo; Nora H de Leeuw; Anne Potter; Richard Stratton; Helen L Birch; Ramona Enea Casse; Laurent Bozec
Journal:  Int J Nanomedicine       Date:  2017-04-21

4.  Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis.

Authors:  Orestis G Andriotis; James Jw Roberts; Phillip D Monk; Philipp J Thurner; Donna E Davies; Mark G Jones; Kerry Lunn; Victoria J Tear; Lucy Cao; Kjetil Ask; David E Smart; Alessandra Bonfanti; Peter Johnson; Aiman Alzetani; Franco Conforti; Regan Doherty; Chester Y Lai; Benjamin Johnson; Konstantinos N Bourdakos; Sophie V Fletcher; Ben G Marshall; Sanjay Jogai; Christopher J Brereton; Serena J Chee; Christian H Ottensmeier; Patricia Sime; Jack Gauldie; Martin Kolb; Sumeet Mahajan; Aurelie Fabre; Atul Bhaskar; Wolfgang Jarolimek; Luca Richeldi; Katherine Ma O'Reilly
Journal:  Elife       Date:  2018-07-03       Impact factor: 8.713

Review 5.  Role of the lysyl oxidase family in organ development (Review).

Authors:  Shanzun Wei; Liang Gao; Changjing Wu; Feng Qin; Jiuhong Yuan
Journal:  Exp Ther Med       Date:  2020-05-08       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.